Lincoln Pharmaceuticals Limited
Dheeraj Kumar Lohia decreased his stake in Lincoln Pharmaceuticals Limited from 1.25% to 1.24%, selling 2,000 shares. The value of his remaining holding is ₹15.3 Cr at ₹615.50 apiece.
A pharmaceutical manufacturer and trader established in 1979, Lincoln Pharma produces a comprehensive range of medicinal products and active pharmaceutical ingredients for domestic and international markets. The company operates across multiple therapeutic segments, delivering quality pharmaceutical formulations to healthcare providers and patients. Lincoln Pharma maintains an established distribution network and manufacturing infrastructure, positioning itself as a supplier within India's pharmaceutical sector.
Known in small-cap circles for buying Shivalik Bimetals around ₹30 and holding through a 20x move, the kind of call that builds a reputation. Dheeraj Kumar Lohia operates through Dheeraj Kumar Lohia and Associates, running a ~₹228 Cr portfolio across 60+ stocks in industrials, pharma, and specialty niches. An early mover who consistently shows up in filings before the crowd arrives.